QGSTM for Function & QPS for Perfusion
The software and algorithms developed by QUAD (formerly AIM) are widely considered to represent the gold standard in nuclear cardiology. You know our software as QGSTM, AutoQUANTTM, and AutoSPECTTM—to name but a few. We have been licensing these applications to companies like GE, Philips, and Siemens for over 20 years. Now they’re available directly from us.
Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 36th Annual Case Review with the Experts - Coming in January 2023
The Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 36th Annual Case Review with…
ASNC 2022 was a success!
After two years of virtual meetings, it was nice to see you all at the…
Cedars-Sinai Ranked #2 Hospital in Nation by U.S. News & World Report
In Annual Best Hospitals Analysis, the Medical Center Also Ranked Nationally in 11 Medical Specialties…
NIH Grant Will Fund Invention of New AI Tools
A $7 Million Grant From the National Heart, Lung, and Blood Institute Will Help Smidt…
Cedars-Sinai Research Recognized at SCCT 2020
Cedars-Sinai Research Recognized at SCCT 2020 Cedars-Sinai physicians and scientists continue their work at the…
Cedars-Sinai Research Recognized at SNMMI 2020
Cedars-Sinai Research Recognized at SNMMI 2020 Nuclear cardiology was at the forefront of SNMMI this…
Reconstruct and motion-correct data without leaving QGSTM + QPS
Built-in AutoRecon and MotoCo.
QGS is a registered trademark of Cedars-Sinai Medical Center. AutoQUANT and AutoSPECT are registered trademarks of Philips, NV.
(844-276-2246), press 1 for Sales